It was reported that TRF-5026a levels are closely correlated with tumour size and that TRF-5026a inhibits gastric cancer cell proliferation, migration, and cell cycle progression by regulating the PTEN/PI3K/Akt signalling pathway. This evidence concerns the gene PIK3CD and neoplasm.